Doxofylline
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161536This classification denotes a phosphodiesterase inhibitor with the molecular formula C11H14N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MPM23GMO7Z, chemically known as 7-(1,3-dioxolon-2-ylmethyl)-1,2,3,6-tetrahydro-1,3-dimethyl-2,6-purindion but generally known as doxofylline, which bears US NIH Compound Identifier 50942. European Medicines Agency schedules Doxofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06390MIG. The term DOXOFYLLINE is an International Non-Proprietary Name. World Health Organization schedules doxofylline in its Anatomical Therapeutic Chemical (ATC) Classification. DOXOFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doxofylline under HS 29395900 and SITC 54145. As of Q4 2014, DOXOFYLLINE remains the US FDA Preferred Term for this commodity. Doxofylline bears US NLM identifiers UMLS ID C0058721 and NCI Concept Code C76317. SMILES: CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.